×
About 575 results

ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center

Research & Reviews  208 results

A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
https://clinicaltrials.gov/ct2/show/NCT04442269

Jan 13th, 2022 - The primary objective of the study is to evaluate the efficacy of dupilumab on the annualized rate of exacerbations in participants with Allergic Bronchopulmonary Aspergillosis (ABPA). The secondary objectives of the study are: To evaluate the eff...

Allergic bronchopulmonary aspergillosis with chest pain as atypical symptoms.
https://doi.org/10.1016/S1473-3099(21)00423-0
The Lancet. Infectious Diseases; Chen TT, Zhou P et. al.

Dec 27th, 2021 - Allergic bronchopulmonary aspergillosis with chest pain as atypical symptoms.|2021|Chen TT,Zhou P,Nie L,Lei Y,Li D,|therapeutic use,diagnostic imaging,drug therapy,drug effects,pathogenicity,microbiology,

Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709957
BMC Pulmonary Medicine; Benkalfate N, Dirou S et. al.

Dec 26th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) is a bronchopulmonary disease caused by a complex hypersensitivity to Aspergillus and is usually associated with underlying respiratory diseases such as asthma or cystic fibrosis. Mucus plugging can l...

Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multic...
https://doi.org/10.1183/13993003.02218-2021
The European Respiratory Journal; Godet C, Couturaud F et. al.

Nov 13th, 2021 - In allergic bronchopulmonary aspergillosis (ABPA), prolonged nebulised antifungal treatment may be a strategy for maintaining remission. We performed a randomised, single-blind, clinical trial in 30 centres. Patients with controlled ABPA after a 4...

Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis
https://clinicaltrials.gov/ct2/show/NCT04502381

Nov 10th, 2021 - Pulmonary mucormycosis is a relatively a rare disease with a high mortality. The angioinvasion associated with mucormycosis prevents efficient drug delivery at the diseased site. Inhaled amphotericin B achieves drug levels in lung tissue and has b...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  8 results

A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
https://clinicaltrials.gov/ct2/show/NCT04442269

Jan 13th, 2022 - The primary objective of the study is to evaluate the efficacy of dupilumab on the annualized rate of exacerbations in participants with Allergic Bronchopulmonary Aspergillosis (ABPA). The secondary objectives of the study are: To evaluate the eff...

Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis
https://clinicaltrials.gov/ct2/show/NCT04502381

Nov 10th, 2021 - Pulmonary mucormycosis is a relatively a rare disease with a high mortality. The angioinvasion associated with mucormycosis prevents efficient drug delivery at the diseased site. Inhaled amphotericin B achieves drug levels in lung tissue and has b...

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
https://clinicaltrials.gov/ct2/show/NCT04966234

Jul 19th, 2021 - Cystic fibrosis (CF) is the most common inherited life-limiting disease in North European people affecting 90,000 people worldwide with about 45,000 registered in the Patient Registry of the European Cystic Fibrosis Society (ECFS). Progressive lun...

CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment
https://clinicaltrials.gov/ct2/show/NCT01533636

May 3rd, 2021 - Pseudomonas lung infection is a major cause of morbidity and mortality occurring in multiple clinical settings. Patients with cystic fibrosis have lung colonization with Pseudomonas from an early age, and overwhelming pseudomonal lung infection is...

Deflazacort vs. Prednisolone in Acute-stage ABPA
https://clinicaltrials.gov/ct2/show/NCT04227483

Feb 23rd, 2021 - Depending on the host immunity and the organism virulence, the respiratory diseases caused by Aspergillus are classified as saprophytic (aspergilloma), allergic (allergic aspergillus sinusitis and allergic bronchopulmonary aspergillosis) and invas...

see more →

News  4 results

Five Things You Need to Know About Bronchiectasis
https://www.medscape.com/viewarticle/955069

Jul 22nd, 2021 - Bronchiectasis is a chronic condition characterised by symptoms of persistent or recurrent bronchial sepsis caused by irreversible damage to and dilation of the bronchi.[1] The key principles of the diagnosis and management of bronchiectasis were ...

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Management of Asthma in the Military
https://www.mdedge.com/fedprac/article/135491/pulmonology/management-asthma-military
Capt Frederic A. Rawlins III, DO, LTC Jacob F. Collen, MD et. al.

Apr 10th, 2017 - Asthma is a chronic inflammatory disorder of the airways that leads to airflow obstruction and bronchial hyperresponsiveness. Clinical features of asthma include episodic cough, wheeze, and dyspnea, which may resolve with avoidance of triggers or.

Eosinophilic Asthma: Reducing Exacerbations and Steroid Use
https://www.medscape.com/viewarticle/838306

Jan 28th, 2015 - This is Andy Shorr from Washington, DC, with the pulmonary literature update. Today I want to highlight a recent article in the New England Journal of Medicine by Ortega and colleagues,[1] who reported the MENSA trial. This study focused on the us...

see more →

Patient Education  3 results see all →